European regulators has approved the world’s first malaria vaccine and now it will be used to protect the millions of children in sub-Saharan Africa from malaria. World Health Organisation will gives guidelines on how and where it should be used before the end of the year.
The Vaccine developed by GlaxoSmithKline. The trade name of this vaccine is Mosquirix.